BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 17438211)

  • 1. What's the problem with generic antiepileptic drugs?: a call to action.
    Berg MJ
    Neurology; 2007 Apr; 68(16):1245-6. PubMed ID: 17438211
    [No Abstract]   [Full Text] [Related]  

  • 2. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
    Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
    Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment: Pharmacy and generic substitution of antiepileptic drugs: missing in action?
    Hatton RC
    Ann Pharmacother; 2007 Sep; 41(9):1550-1; author reply 1551-2. PubMed ID: 17652128
    [No Abstract]   [Full Text] [Related]  

  • 4. Lessons learned in Reno.
    Contillo C
    Am J Nurs; 2011 Jan; 111(1):11. PubMed ID: 21191208
    [No Abstract]   [Full Text] [Related]  

  • 5. [Generics of antiepileptic drugs].
    Maeder-Ingvar M; Foletti GB
    Rev Med Suisse; 2010 May; 6(247):907-9. PubMed ID: 20499577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic medications: another variable in the treatment of illnesses.
    Blier P
    J Psychopharmacol; 2007 Jul; 21(5):459-60. PubMed ID: 17664245
    [No Abstract]   [Full Text] [Related]  

  • 7. Are generic drugs really inferior medicines?
    Moore N; Berdaï D; Bégaud B
    Clin Pharmacol Ther; 2010 Sep; 88(3):302-4. PubMed ID: 20725079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of gullibility.
    Roach ES
    Arch Neurol; 2009 Nov; 66(11):1418-20. PubMed ID: 19901178
    [No Abstract]   [Full Text] [Related]  

  • 9. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.
    Liow K; Barkley GL; Pollard JR; Harden CL; Bazil CW;
    Neurology; 2007 Apr; 68(16):1249-50. PubMed ID: 17438213
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of specifying brand-name antiepileptic drugs.
    Ng YT
    Arch Neurol; 2009 Nov; 66(11):1415-6. PubMed ID: 19901176
    [No Abstract]   [Full Text] [Related]  

  • 11. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy: what's the problem with generic antiepileptic drugs? A call to action.
    Miller JW; Anderson GD; Doherty MJ; Poolos NP
    Neurology; 2007 Oct; 69(18):1806-8. PubMed ID: 17967998
    [No Abstract]   [Full Text] [Related]  

  • 12. Generic anticonvulsant use in children: do we have evidence to recommend brand formulations?
    Hamiwka LD
    Arch Neurol; 2009 Nov; 66(11):1417-8. PubMed ID: 19901177
    [No Abstract]   [Full Text] [Related]  

  • 13. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
    Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing generic antiepileptic drugs: Issues and concerns for nurse practitioners.
    Barrett MW
    J Am Acad Nurse Pract; 2010 Jun; 22(6):300-4. PubMed ID: 20536627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic prescribing in epilepsy.
    Drug Ther Bull; 2009 Dec; 47(12):141-4. PubMed ID: 20009042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antiepileptic drug substitutions on epileptic events requiring acute care.
    Rascati KL; Richards KM; Johnsrud MT; Mann TA
    Pharmacotherapy; 2009 Jul; 29(7):769-74. PubMed ID: 19558250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of epilepsies for general practitioners].
    Stefan H
    MMW Fortschr Med; 2009 Mar; 151(13):49-52. PubMed ID: 19504819
    [No Abstract]   [Full Text] [Related]  

  • 18. Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial.
    Privitera MD; Welty TE; Gidal BE; Diaz FJ; Krebill R; Szaflarski JP; Dworetzky BA; Pollard JR; Elder EJ; Jiang W; Jiang X; Berg M
    Lancet Neurol; 2016 Apr; 15(4):365-72. PubMed ID: 26875743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
    Gidal BE; Tomson T
    Epilepsia; 2008 Dec; 49 Suppl 9():56-62. PubMed ID: 19087118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the safety and comparative effectiveness of follow-on biologics (biosimilars) in the United States.
    Hennessy S; Leonard CE; Platt R
    Clin Pharmacol Ther; 2010 Feb; 87(2):157-9. PubMed ID: 20107450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.